THE
INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE
COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE
MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH HAS BEEN
INCORPORATED INTO UK LAW BY THE EUROPEAN UNION (WITHDRAWAL) ACT
2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA
REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
24 June 2024
Belluscura
plc
("Belluscura" or the
"Company")
Update re proposed placing of
convertible loan notes
Subscription for new ordinary
shares to raise £300,000
Total voting
rights
LONDON, U.K. AND PLANO, TX, U.S. (24 June 2024).
Belluscura plc (AIM: BELL), announced on 12 June
2024 a proposed placing of convertible loan notes. The Company has
received significant interest in, and demand for, the proposed
placing from new and existing investors and anticipates being able
to provide an update as to final terms, including the issue size,
shortly.
Details of subscription for new ordinary
shares
Separately, an investor has
approached the Company expressing an interest in subscribing for
new ordinary shares of 1 penny each in the Company ("Ordinary Shares"). Consequently,
utilising the Directors' existing share authorities to issue
Ordinary Shares for cash on a non-pre-emptive basis, the Company
has raised gross proceeds of £300,00.00 through a subscription by
such investor for, and the allotment and issue by the Company of,
2,000,000 new Ordinary Shares (the "Subscription Shares") at an issue price
of 15 pence (the "Subscription
Price") per Subscription Share (the "Subscription").
The net proceeds of the Subscription
will be used for working capital purposes. The Subscription Price
of 15 pence per Subscription Share represents a discount of 7.7 per
cent. to the closing mid-market price of 16.25 pence per existing
Ordinary Share on 21 June 2024 (being the last business day prior
to this announcement).
Application for Admission
Application has been made for the
Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that
Admission will become effective and that dealings will commence at
8.00 a.m. on or around 25 June 2024. Once issued, the Subscription
Shares will rank pari
passu with the Company's existing Ordinary
Shares.
Total voting rights
Following Admission, the enlarged
issued share capital of the Company will comprise 167,032,567
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Consequently, 167,032,567 is the figure which may be used
by shareholders as the denominator for the calculation by which
they will determine if they are required to notify their interest
in, or a change to their interest in, the Company under the
Financial Conduct Authority's Disclosure Guidance and Transparency
Rules.
For
further information please contact:
Belluscura plc
|
Tel: +44
(0)20 3128 8100
|
Adam Reynolds, Chairman
|
|
Robert Rauker, Chief Executive
Officer
|
|
Simon Neicheril, Chief Financial
Officer
|
|
|
|
SPARK Advisory Partners Limited - Nominated
Adviser
|
Tel: +44
(0)20 3368 3550
|
Neil Baldwin / Jade Bayat
|
|
|
|
Dowgate Capital Limited - Broker
|
Tel: +44
(0)20 3903 7715
|
Russell Cook / Nicholas
Chambers
|
|
|
|
MHP
Group - Financial PR & Investor Relations
|
Tel: +44
(0)20 3128 8100
|
Katie Hunt / Matthew
Taylor
|
email:
Belluscura@mhpgroup.com
|
|
|